Functional foods and nutraceuticals

01Overview and value chain#

Markers EC: EU Health Claims Regulation (EC) 1924/2006 — functional-food claim substantiation | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)

Functional foods and nutraceuticals cover food and supplement products engineered to deliver a specific, substantiated health benefit beyond basic nutrition — immunity, healthy aging, gut health — rather than a generic wellness claim. The category’s center of gravity is shifting from one-size-fits-all supplements toward personalization: Danone’s Singapore D-Lab is applying AI and digital tools to healthy-ageing nutrition and screening, and industry surveys identify a broader “MegaTrend” shift from generic offerings to nutrition that responds to an individual’s own data. ADM is positioning postbiotics specifically as a next-generation ingredient for healthy aging across mood, sleep and metabolism, while Amway’s Nutrilite brand continues to build immunity-support formulations that combine traditional herbal actives (turmeric, licorice) with vitamin C. Consolidation is already reshaping the challenger-brand tier: Hindustan Unilever agreed to fully acquire India’s OZiva, a clean-label protein and women’s-health supplement brand, for roughly $90 million in February 2026.

Key directions of functional foods and nutraceuticals:

1. Personalized nutrition platforms (Personalized Nutrition Platforms): AI- and data-driven tools (nutrigenetics, gut-microbiome profiling) tailoring a functional-food or supplement recommendation to an individual.
2. Postbiotic and next-generation biotic ingredients (Postbiotic Ingredients): non-living microbial-derived ingredients positioned for specific outcomes (healthy aging, mood, sleep, metabolism) beyond classic probiotics.
3. Traditional-herbal/vitamin combination formulations (Traditional- Herbal/Vitamin Combination Formulations): blending long-established botanicals with vitamins into a single immunity- or wellness-targeted product.
4. Challenger clean-label brand consolidation (Challenger Clean-Label Brand Consolidation): large incumbents acquiring fast-growing, digitally native supplement brands rather than building the same positioning in-house.

Sectoral value chain#

[health-benefit target] ──> [ingredient/formulation R&D] ──> [claim substantiation] ──> [product formulation]
                                                                     │
                                                             (regulatory
                                                              claim review)
                                                                     │
                                                                     ▼
[retail/DTC sale] <─── [brand positioning] <────────────────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Nutrigenetic/microbiome personalization (Nutrigenetic/Microbiome Personalization): integrating an individual’s genetic or gut-microbiome data into a product or shopping recommendation.
• Postbiotic ingredient standardization (Postbiotic Ingredient Standardization): producing non-living, microbial-derived ingredients with consistent, claims-ready composition.
• Health-claim substantiation pipelines (Health-Claim Substantiation Pipelines): structured clinical/scientific evidence generation designed specifically to clear a regulator’s claim-approval bar.

02US#

The US hosts both a long-established herbal-nutraceutical brand and a global ingredient supplier pivoting toward next-generation biotic ingredients.

postbiotic ingredient innovation, herbal/vitamin immunity formulations, healthy-aging positioning#

• ADM: positions postbiotics as a next-generation biotic ingredient for healthy-aging functional foods, targeting mood, sleep and metabolism outcomes alongside its broader protein-ingredient innovation.
• Amway Nutrilite: builds immunity-support formulations combining traditional herbal actives (turmeric, licorice, Amalaki/Vibhitaki/Haritaki) with vitamin C, alongside concentrated fruit-and-vegetable phytonutrient products.

03CN#

Public information on a dedicated Chinese functional-foods/nutraceuticals originator distinct from the region’s broader supplement manufacturing base was not confirmed in this pass; the section stays at the policy level.

functional-food market research activity, nanoencapsulation research, no confirmed flagship originator#

• Active market-research interest: Chinese industry research reports track functional-food market size and growth forecasts, reflecting significant commercial interest in the category.
• Nanoencapsulation research base: academic work on nanoencapsulation of nutraceuticals for improved stability and bioavailability is active, ahead of a confirmed flagship commercial originator in this specific pass.
• No confirmed flagship originator: a Chinese company matching the personalization/postbiotic positioning seen in the US/EU leaders was not confirmed via live sources in this pass.

04EU#

The EU is applying AI and digital tools to personalize functional nutrition around specific life stages, anchored by a health-claim regulation that gates every functional-food claim made in the market.

AI-driven personalized nutrition, healthy-ageing screening tools, EU health-claim substantiation#

• Danone Nutricia Research: its Singapore D-Lab applies AI and digital capabilities to develop health-screening tools and nutrition solutions supporting healthy ageing, part of a broader industry shift toward nutrigenetics- and microbiome-informed personalization.
• Personalization as a stated industry MegaTrend: industry trend analysis identifies the shift from generic functional-nutrition offerings to individually responsive products as a defining 2026 direction.
• EU Regulation (EC) 1924/2006: requires every functional-food health claim to be scientifically substantiated and formally authorized before use in EU marketing.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack combines personalization data with claims-grade ingredient science.

1. AI-driven nutrition personalization (AI-Driven Nutrition Personalization):
   • digital tools integrate nutrigenetic and gut-microbiome data to tailor a nutrition or shopping recommendation to an individual.
   • case: Danone’s D-Lab applies AI and digital capabilities specifically to healthy-ageing screening and nutrition solutions.
2. Postbiotic ingredient engineering (Postbiotic Ingredient Engineering):
   • non-living, microbial-derived ingredients are standardized and positioned for specific outcomes beyond classic live-probiotic claims.
   • case: ADM backs postbiotics specifically to drive healthy-aging innovation across mood, sleep and metabolism claims.
3. Challenger-brand claims positioning (Challenger-Brand Claims Positioning):
   • digitally native brands build a clean-label, claims-specific position (protein, women’s health) that becomes an acquisition target for incumbents.
   • case: Hindustan Unilever’s ~$90 million acquisition of OZiva brought a clean-label protein and women’s-health brand directly into an incumbent’s portfolio.

07Value chains and production pipelines#

Industrial pipeline of a claims-substantiated functional food (EU Health Claims Regulation)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Health-benefit target  │ ───> │ 2. Ingredient/formulation R&D│
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Product formulation    │ <─── │ 3. Claim substantiation   │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Regulatory claim review│ ───> │ 6. Retail/DTC launch      │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Health-benefit target

A specific outcome — immunity, healthy aging, gut health, women’s health — is selected as the product’s target claim.

Stage 2: Ingredient/formulation R&D

Active ingredients (postbiotics, herbal actives, vitamins) are selected or developed to address the target outcome.

Stage 3: Claim substantiation

Clinical or scientific evidence is generated to support the specific health claim being made.

Stage 4: Product formulation

The substantiated ingredient is finalized into a food, drink or supplement product format.

Stage 5: Regulatory claim review

The health claim clears FDA review or EU Regulation 1924/2006 authorization before it can be marketed.

Stage 6: Retail/DTC launch

The product reaches consumers through retail or direct-to-consumer channels, with brand positioning increasingly a driver of acquisition activity in the category.